278 related articles for article (PubMed ID: 9645958)
1. Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex.
Ringheim GE; Szczepanik AM; Petko W; Burgher KL; Zhu SZ; Chao CC
Brain Res Mol Brain Res; 1998 Mar; 55(1):35-44. PubMed ID: 9645958
[TBL] [Abstract][Full Text] [Related]
2. Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R).
Lust JA; Jelinek DF; Donovan KA; Frederick LA; Huntley BK; Braaten JK; Maihle NJ
Curr Top Microbiol Immunol; 1995; 194():199-206. PubMed ID: 7895493
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta.
Vallières L; Rivest S
J Neurochem; 1997 Oct; 69(4):1668-83. PubMed ID: 9326296
[TBL] [Abstract][Full Text] [Related]
4. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts.
Vermes C; Jacobs JJ; Zhang J; Firneisz G; Roebuck KA; Glant TT
J Biol Chem; 2002 May; 277(19):16879-87. PubMed ID: 11884403
[TBL] [Abstract][Full Text] [Related]
5. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.
Oh JW; Van Wagoner NJ; Rose-John S; Benveniste EN
J Immunol; 1998 Nov; 161(9):4992-9. PubMed ID: 9794436
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional inhibition of the beta-amyloid precursor protein by interferon-gamma.
Ringheim GE; Szcepanik AM; Burgher KL; Petko W; Heroux JA; Cavalieri F
Biochem Biophys Res Commun; 1996 Jul; 224(1):246-51. PubMed ID: 8694821
[TBL] [Abstract][Full Text] [Related]
7. Generation of 'truncated' interleukin-6 receptor (IL-6R) mRNA by alternative splicing; a possible source of soluble IL-6R.
Holub MC; Szalai C; Polgár A; Tóth S; Falus A
Immunol Lett; 1999 May; 68(1):121-4. PubMed ID: 10397166
[TBL] [Abstract][Full Text] [Related]
8. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production.
Igaz P; Horváth A; Horváth B; Szalai C; Pállinger E; Rajnavölgyi E; Tóth S; Rose-John S; Falus A
Immunol Lett; 2000 Mar; 71(3):143-8. PubMed ID: 10722865
[TBL] [Abstract][Full Text] [Related]
9. Selective induction of MCP-1 in human mesangial cells by the IL-6/sIL-6R complex.
Coletta I; Soldo L; Polentarutti N; Mancini F; Guglielmotti A; Pinza M; Mantovani A; Milanese C
Exp Nephrol; 2000; 8(1):37-43. PubMed ID: 10644881
[TBL] [Abstract][Full Text] [Related]
10. Fast modulation of heat-activated ionic current by proinflammatory interleukin 6 in rat sensory neurons.
Obreja O; Biasio W; Andratsch M; Lips KS; Rathee PK; Ludwig A; Rose-John S; Kress M
Brain; 2005 Jul; 128(Pt 7):1634-41. PubMed ID: 15817518
[TBL] [Abstract][Full Text] [Related]
11. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S
Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117
[TBL] [Abstract][Full Text] [Related]
12. A combination of interleukin-6 and its soluble receptor impairs sperm motility: implications in infertility associated with endometriosis.
Yoshida S; Harada T; Iwabe T; Taniguchi F; Mitsunari M; Yamauchi N; Deura I; Horie S; Terakawa N
Hum Reprod; 2004 Aug; 19(8):1821-5. PubMed ID: 15166129
[TBL] [Abstract][Full Text] [Related]
13. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
[TBL] [Abstract][Full Text] [Related]
14. How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2?
Kovacs E
Biomed Pharmacother; 2003 Dec; 57(10):489-94. PubMed ID: 14637393
[TBL] [Abstract][Full Text] [Related]
15. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases.
Kallen KJ
Biochim Biophys Acta; 2002 Nov; 1592(3):323-43. PubMed ID: 12421676
[TBL] [Abstract][Full Text] [Related]
16. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
[TBL] [Abstract][Full Text] [Related]
17. Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor.
Klouche M; Bhakdi S; Hemmes M; Rose-John S
J Immunol; 1999 Oct; 163(8):4583-9. PubMed ID: 10510402
[TBL] [Abstract][Full Text] [Related]
18. A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA.
Oh JW; Revel M; Chebath J
Cytokine; 1996 May; 8(5):401-9. PubMed ID: 8726669
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures.
Franchimont N; Durant D; Canalis E
Endocrinology; 1997 Aug; 138(8):3380-6. PubMed ID: 9231791
[TBL] [Abstract][Full Text] [Related]
20. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
